PATMI grew 9.5% YoY to stand at LKR334m for 1HFY16, on the back of a 21.3% YoY growth in PAT to LKR669m despite challenges in the Agri sector.
All segments, apart from Agri (38.2% of Group Revenue) which contracted 11.6% YoY, contributed towards top-line growth during 1HFY16.
Group’s Healthcare sector (40.2% of Group Revenue) grew 17.3% YoY, and FMCG (18.5% of Group Revenue) grew 19.9% YoY against same period last year.
For 1HFY16, PAT amounted to LKR669m up 21.3% YoY, which trickled down to Profit After Tax and Minority Interest (PATMI) which went up by 9.5% YoY to LKR334m.
PAT from both Agri and FMCG sectors has a lower impact on the group PATMI due to lower effective holding.
Healthcare still remains the largest contributor to PATMI in 1HFY16 with LKR180m, which represents 54.0% of total PATMI.
Net Asset Value per Share increased to LKR40.78 as at end 1HFY16, compared to LKR39.24 at the beginning of the year (FY15).
Business Segments
Healthcare
Healthcare Revenue for 1HFY16 grew 17.3% YoY, exceeding management expectations, to stand at LKR3.4bn.
The Healthcare segment has overtaken Agri to be the biggest contributor to Group Revenue, accounting for 40.2% of the total.
EBIT margin for 1HFY16 increased by 10 bps to 7.9% on the back of tight cost control, despite supply-side pressure from business partners.
2QFY16 EBIT margin expanded to 8.3% against 7.9% during the same quarter last year due to higher productivity.
The Pharma sub segment which made LKR2.3bn in revenues (66.3% of Healthcare Revenue) grew 16.5% YoY over 1HFY15.
Strong growth in this segment has outperformed the overall market which grew 4.8% YoY as reported by IMS.
The company’s Pharma segment is the 2nd biggest player in the country with 11.7% share of the market. Growth in other sub sectors were: Surgical (+15.2% YoY), Retail (+17.8% YoY), Diagnostics (+38.6% YoY), Wellness (+25.7% YoY) respectively.
PAT for Healthcare amounted to LKR180m in 1HFY16, up 16.6% YoY, but margins remained flat at 5.3% where GP margin pressure from suppliers were countered by higher productivity and tight control in overheads.
FMCG
The FMCG sector reported revenues of LKR1.6bn in 1HFY16, up 19.9% YoY, on the back of both volume and price growth, and the sector accounted for 18.5% of Group Revenue for the period.
The branded tea business within FMCG sold 1.7m kg of branded tea, up 11.1% YoY, primarily driven by their largest brand ‘Watawala Tea’ – which is the number one selling Tea brand in Sri Lanka.
PAT from the FMCG segment grew 85.1% YoY, to stand at LKR228m in 1HFY16, with a margin of 14.4%, compared to 9.3% in the same period last year.
The huge spike in profitability is attributable to lower raw material costs, resulting from depressed Ceylon Tea prices which affects the FMCG business favorably.
Agribusiness
The sector represented by Watawala Plantations PLC (WATA) saw revenue contract by 11.4% YoY to LKR3.3bn, on the back of a 22.3% YoY contraction in Tea revenue, despite an 8.8% YoY increase in volumes.
The segment was adversely affected by the weak market prices in the Colombo Tea Auction stemming from lower demand from key export markets.
The Palm Oil sub sector grew by 5.3% YoY for 1HFY16, with volumes similar to 1HFY15.
PAT for 1HFY16 amounted to LKR262m, similar to that reported for the same period last year.
Loss for the Tea segment amounted to LKR243m in 1HFY16, compared to a loss of LKR199m in 1HFY15 on the back of lower sales.
Palm Oil segment which made LKR467m PAT for 1HFY16, continued to be the largest contributor to WATA profits and managed to cover the losses in both Tea and Rubber.
Other
Packaging revenues amounted to LKR169m, up 22.1% YoY in 1HFY16, against LKR137m in the same period last year.
This performance is in line with management expectations for the segment, with the printed sheet business ramping up its contribution to Revenue.
PAT amounted to LKR7m in 1HFY16 compared to a loss of (LKR7m) in 1HFY15 as a result of improved capacity utilization coming from new export orders.
Revenue for the Renewable Energy division amounted to LKR62m in 1HFY16, up 34.8% YoY from LKR46m during same period last year, due to heavy inter-monsoon rainfall and improved plant and grid stability.
The mini-hydro plant, which is in its second year of operation, made PAT of LKR21m for 1HFY16, compared to LKR2m in 1HFY15.
ABOUT SUNSHINE HOLDINGS
Sunshine Holdings PLC is a diversified holding company contributing to ‘nation building’ by creating value in vital sectors of the Sri Lankan economy – including healthcare, agribusiness, fast moving consumer goods and renewable energy.
Many of its business units are leaders in their respective sectors, have secured partnerships with multiple top global brands and have won prestigious awards at the national as well as the regional level.
The leading brands of the group include Zesta, Healthguard, Watawala Tea, Pedia Plus and Diabeta Plus.
Sunshine Holdings’ jointly-owned plantation company is Sri Lanka’s largest palm oil producer and has also been the country’s largest tea producer for several consecutive years.
The company’s healthcare marketing unit is the second largest in its sector nationally.
Its tea sector also consists of Sri Lanka’s best-selling tea brand locally.
The group, which provides employment to approximately 12,000, generates over US$ 120 million in revenue. Sunshine Holdings is consistently ranked among the LMD Top 50 companies in Sri Lanka.
For more information, please visit our Investor Relations page. http://www.sunshineholdings.lk/investor%20relations/index.php